Trial | NCT02614963  Report issue

Title

Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome: A Randomized, Double-blinded,Placebo- Controlled Multicenter Study

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    300
Clostridium Butyricum might be an effective drug in treating irritable bowel syndrome
Study Started
Dec 31
2015
Primary Completion
Jul 31
2016
Anticipated
Study Completion
Jul 31
2016
Anticipated
Last Update
May 17
2016
Estimate

Drug Clostridium Butyricum

Irritable bowel syndrome patients treated with Clostridium Butyricum

Drug placebo

Irritable bowel syndrome patients treated with placebo

Clostridium Butyricum group Experimental

Irritable bowel syndrome patients treated with Clostridium Butyricum

Placebo group Placebo Comparator

Irritable bowel syndrome patients treated with placebo

Criteria 

Inclusion Criteria:

the presence of Rome III criteria for IBS ;
Aged between 18 and 65 years old

Exclusion Criteria:

Antibiotic, probiotic or laxative usage within 4 weeks.
organic gastrointestinal diseases
Severe systematic disease: diabetes mellitus, hepatic, renal or cardiac dysfunction, thyroid disease or tumor etc.
pregnancy or lactation.
previous major or complicated abdominal surgery.
severe endometriosis and dementia
No Results Posted